You are here

Home ยป Company Details

PATHOVACS INCORPORATED

Company Information
Address
1024 ROY J CARVER CO-LABORATORY ISU
AMES, IA 50011-0001
United States
Information

UEI: GAEYBFGAB1N9

# of Employees: 3
Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No

Award Charts




Award Listing

  • Record 1 TO 6

  1. A Simple at-home test for rapid and accurate screening for Hepatitis C Virus (HCV) exposure

    Amount: $393,833.00

    Development and feasibility demonstration of a prototype rapid and accurate Lateral Flow Assay (LFA) to self-screen qualitatively for exposure to Hepatitis C Virus (HCV) in at-home settings, is propos ...

    SBIRPhase I2022Department of Health and Human Services National Institutes of Health

  2. Broadly Protective Porcine Streptococcus suis Vaccines

    Amount: $649,999.00

    Toward efficacious porcine Streptococcus suisvaccines for use globally in the feasibility SBIRPhase I component we demonstrated proof-of-concept for cross-protection engendered by amultivalent subunit ...

    SBIRPhase II2022Department of Agriculture

  3. Circulating Diagnostic Markers of Infectious Disease

    Amount: $975,605.70

    Assays for accurate diagnosis of early stages of infection with biothreat agents, on the day of infection or within a few days of infection, will find wide use in both civilian and military applicatio ...

    STTRPhase II2020Department of Defense Office for Chemical and Biological Defense

  4. Broadly protective porcine Streptococcus suis vaccines

    Amount: $99,546.00

    Non-technical SummaryCurrently, there are no efficacious vaccines to protect piglets against disease caused by the emerging zoonotic (transmissible from animals to humans) pathogen, Streptococcus suis ...

    SBIRPhase I2018Department of Agriculture

  5. Circulating Diagnostic Markers of Infectious Disease

    Amount: $149,503.95

    The focus of this STTR phase I component is on proof-of-concept studies demonstrating applicability of technical approaches for identificationof circulatory diagnostic markers for infectious disease. ...

    STTRPhase I2018Department of Defense Office for Chemical and Biological Defense

  6. Immunologically cross reactive proteins for broadly protective Campylobacter chicken vaccines

    Amount: $99,750.00

    Human Campylobacter disease caused by the foodborne pathogens, Campylobacter jejuni and Campylobacter coli, is a huge public health problem globally. The economic burden of this disease, which ranges ...

    SBIRPhase I2012Department of Agriculture
US Flag An Official Website of the United States Government